We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Siemens Healthineers - Laboratory Diagnostics

Provides advanced laboratory diagnostics solutions for the medical industry read more Featured Products: More products

Download Mobile App




Automated Urine Microscopy Analyzer Detects Uropathogen Morphology

By LabMedica International staff writers
Posted on 26 Jan 2021
Print article
Image: The Atellica UAS800 is a completely automated urine sediment analyzer powered by advanced high-resolution digital imaging (Photo courtesy of Siemens Healthineers).
Image: The Atellica UAS800 is a completely automated urine sediment analyzer powered by advanced high-resolution digital imaging (Photo courtesy of Siemens Healthineers).
Urinary tract infection (UTI) is an infectious disease frequently encountered in daily life and is a representative infection that can cause serious sepsis. UTIs are very difficult to diagnose, and unnecessary treatment with antibacterial drugs of conditions with positive urine culture due to asymptomatic bacteria and vulvar‐contaminated urine is often wasteful.

Currently, the gold standard method of identifying the causative organism of UTI is by bacterial culture, but such tests require long testing time, and obtaining test results concurrently with outpatient treatment is generally impossible. In recent years, automated microscopy has become the main tool currently used worldwide for automated urinary analysis.

Clinical Laboratory Scientists at the Tenri Health Care University (Tenri, Japan) examined 118 outpatient spot urine samples in which pyuria and bacteriuria (were observed using flow cytometry (training set: 81; cross‐validation set: 37). The team performed Gram‐stain microscopy analysis and urinary culture and conducted strain identification of the grown colonies by matrix‐assisted laser desorption ionization time‐of‐flight mass spectrometry (MALDI‐TOF MS). They used a MALDI Biotyper (Bruker Daltonics, Bremen, Germany).

The scientists used the Atellica UAS800 (Siemens K.K., Tokyo, Japan) which can measure 14 items: total bacteria (BAC), bacilli (BACr), cocci (BACc), erythrocytes (RBC), leukocytes (WBC), hyaline casts (HYA), squamous epithelial cells (EPI), nonsquamous epithelial cells (NEC), crystals (CRY), leukocyte clumps (WBCc), pathological casts (PAT), yeasts (YEA), mucus (MUC), and sperm (SPRM). The Atellica UAS800 is an automated urine microscopy analyzer whose method is based on the principle of capturing and analyzing microscopic images with a digital camera.

The investigators reported that the Atellica UAS800 detection sensitivity was 106 CFU/mL, and reproducibility in that range was good, but data reliability for the number of cocci was low. Multiple logistic regression analysis with each explanatory variable (14 items from the Atellica UAS800, age and sex) showed the best prediction formula for discrimination of uropathogen morphology was a model with five explanatory variables: number of bacilli, squamous epithelial cells, age, number of cocci, and erythrocytes. For a predicted cutoff value of 0.449, sensitivity was 0.879 and specificity was 0.854. In the cross‐validation set, sensitivity was 0.813 and specificity was 0.857.

The authors concluded that the Atellica UAS800 could detect squamous epithelial cells, an indicator of vaginal contamination, with high sensitivity, which further improved performance. Simultaneous use of this probability prediction formula with urinalysis results may facilitate real‐time prediction of uropathogens and vaginal contamination, thus providing helpful information for empiric therapy. The study was published on January 10, 2021 in the Journal of Clinical Laboratory Analysis.

Related Links:
Bruker Daltonics
Tenri Health Care University
Siemens K.K.


Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Unstirred Waterbath
HumAqua 5
New
Malondialdehyde HPLC Test
Malondialdehyde in Serum/Plasma – HPLC

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.